Jun. 25 at 1:57 PM
$ABCL has been on an absolute tear, surging over 15% in just two days and reclaiming the
$6 mark!
Looking ahead, biotech could easily pull off semiconductor-style explosive moves as AI for drug discovery goes mainstream.
AI will drastically cut down trial times and cash burn rates.
With a rock-solid
$655M cash position,
$ABCL is perfectly positioned to leverage this massive macro shift.
Any healthy pullback from here would offer a premier technical setup to load up heavily for the long term.
